跳至主要内容
临床试验/NCT04727489
NCT04727489招募中不适用

Study of the Genetic Factors Involved in Autism and Related Disorders

Institut National de la Santé Et de la Recherche Médicale, France6 个研究点 分布在 1 个国家目标入组 3,800 人开始时间: 2021年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,800
试验地点
6
主要终点
Prevalence of synaptic gene deleterious mutations in patients with Autism Spectrum Disorder

研究概览

简要总结

The main objective of the study is to define, for Autism Spectrum Disorder, the extent of genetic variation in synaptic pathways that may be targeted for therapeutic development. For this purpose the investigators will take advantage of large, well-characterized cohorts of patients with Autism Spectrum Disorder for genetic screenings. Targeted sequencing of selected synaptic genes, previously associated with Autism Spectrum Disorder, will be carried out in these cohorts with deep coverage of coding regions and a strong focus on previously untested regulatory regions. Genomic data from Copy Number Variant, whole genome sequencing and exome sequencing, available for some of these patients, will be integrated in the overall analysis. The investigators will strongly emphasize the establishment of comprehensive genotype/phenotype correlations.

详细描述

Aim 1: To identify genetic variants in selected synaptic genes, by targeted sequencing with deep coverage of coding regions and a strong focus on previously untested regulatory regions in Autism Spectrum Disorder

Aim 2: To define the range of clinical phenotypes caused by mutations in synaptic genes by establishing detailed genotype/phenotype correlations and analyzing segregation in families with multiple individuals affected by Autism Spectrum Disorder, Autism Spectrum Disorder traits or other neuropsychiatric disorders

Aim 3: To identify the neuronal phenotypes caused by deleterious synaptic mutations for further translational studies

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
24 Months 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Prevalence of synaptic gene deleterious mutations in patients with Autism Spectrum Disorder

时间窗: up to 12 months after completion of the inclusion and molecular explorations

Prevalence of synaptic gene deleterious mutations in patients with Autism Spectrum Disorder

次要结局

  • Prevalence of the deleterious mutations in the major biological pathways in Autism Spectrum Disorder(up to 12 months after completion of the inclusion and molecular explorations)

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验